NCT00870441View on ClinicalTrials.gov

Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Safety of ASP2151
Interventions
DRUG

ASP2151

Oral

DRUG

Valacyclovir

Oral

DRUG

Placebo

Oral

Trial Locations (5)

32117

Daytona Beach

47710

Evansville

75247

Dallas

78752

Austin

96813

Honolulu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY